Compare Kinross Gold Corporation (KGC) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinross Gold Corporation vs Eli Lilly And Co — how do they compare? Kinross Gold Corporation trades at $23.45 (market cap $26.63B), while Eli Lilly And Co trades at $1,170.93 (market cap $1.02T). The key difference: Eli Lilly And Co is far larger — about 38.3× Kinross Gold Corporation's market cap, and Kinross Gold Corporation pays the higher dividend (0.64%). Which is the better fit depends on your goals.
| KGC | LLY | |
|---|---|---|
Market Cap | $26.63B | $1.02T |
Sector | Basic Materials | Health |
52-Week High | $38.06 | $1.24K |
52-Week Low | $15.42 | $625.65 |
Enterprise Value | $25.18B | $1.06T |
Dividend Yield | 0.64% | 0.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
